Ralliant (NYSE:RAL) Upgraded by Wall Street Zen to Strong-Buy Rating

Wall Street Zen upgraded shares of Ralliant (NYSE:RAL) from a buy rating to a strong-buy rating in a research report released on Saturday morning.

A number of other research firms have also recently weighed in on RAL. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a research note on Friday, July 31st. TD Cowen increased their target price on shares of Ralliant from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Evercore assumed coverage on shares of Ralliant in a research note on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price target for the company. Morgan Stanley lifted their price target on shares of Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a report on Tuesday, June 23rd. Finally, Citigroup upped their price objective on Ralliant from $81.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Ralliant has a consensus rating of “Moderate Buy” and a consensus target price of $75.70.

Ralliant Trading Down 0.3%

NYSE RAL opened at $63.72 on Friday. The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of -5.87, a PEG ratio of 2.36 and a beta of 1.60. Ralliant has a one year low of $37.27 and a one year high of $75.41. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. The business’s fifty day moving average is $68.94 and its 200-day moving average is $55.92.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. The company had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Equities research analysts predict that Ralliant will post 2.87 EPS for the current year.

Ralliant Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant’s payout ratio is currently -1.84%.

Insider Activity

In other Ralliant news, SVP Karen M. Bick sold 6,062 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $72.00, for a total transaction of $436,464.00. Following the sale, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. This represents a 16.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the transaction, the chief executive officer owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This represents a 4.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of RAL. BlackRock Inc. bought a new stake in Ralliant during the 2nd quarter valued at $1,039,481,000. Dodge & Cox lifted its position in shares of Ralliant by 13.3% during the fourth quarter. Dodge & Cox now owns 12,214,679 shares of the company’s stock worth $621,849,000 after acquiring an additional 1,434,376 shares in the last quarter. Viking Global Investors LP bought a new position in shares of Ralliant in the second quarter worth $257,200,000. Millennium Management LLC boosted its holdings in shares of Ralliant by 172.4% in the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after acquiring an additional 3,147,660 shares during the period. Finally, State Street Corp purchased a new position in shares of Ralliant in the second quarter valued at $213,096,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.